Celanese CE has been analyzed by 15 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 6 | 7 | 2 | 0 |
| Last 30D | 0 | 1 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 2 | 1 | 0 |
| 2M Ago | 0 | 3 | 2 | 0 | 0 |
| 3M Ago | 0 | 2 | 2 | 1 | 0 |
Analysts have set 12-month price targets for Celanese, revealing an average target of $167.67, a high estimate of $190.00, and a low estimate of $144.00. Surpassing the previous average price target of $163.87, the current average has increased by 2.32%.
Analyzing Analyst Ratings: A Detailed Breakdown
The standing of Celanese among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Patrick Cunningham | Citigroup | Lowers | Neutral | $148.00 | $167.00 |
| Michael Sison | Wells Fargo | Lowers | Overweight | $180.00 | $195.00 |
| John McNulty | BMO Capital | Maintains | Market Perform | $158.00 | $158.00 |
| David Begleiter | Deutsche Bank | Lowers | Hold | $160.00 | $175.00 |
| Steve Byrne | B of A Securities | Lowers | Underperform | $144.00 | $147.00 |
| Charles Neivert | Piper Sandler | Raises | Overweight | $180.00 | $170.00 |
| John McNulty | BMO Capital | Raises | Market Perform | $158.00 | $153.00 |
| Arun Viswanathan | RBC Capital | Raises | Outperform | $176.00 | $171.00 |
| Ghansham Panjabi | Baird | Raises | Outperform | $180.00 | $165.00 |
| Kieran De Brun | Mizuho | Raises | Neutral | $173.00 | $161.00 |
| Arun Viswanathan | RBC Capital | Raises | Outperform | $171.00 | $165.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $167.00 | $150.00 |
| Aleksey Yefremov | Keybanc | Raises | Overweight | $190.00 | $176.00 |
| Michael Leithead | Barclays | Maintains | Equal-Weight | $170.00 | $170.00 |
| Jeffrey Zekauskas | JP Morgan | Raises | Underweight | $160.00 | $135.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Celanese. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Celanese's stock. This analysis reveals shifts in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Celanese's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Celanese analyst ratings.
All You Need to Know About Celanese
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
Financial Milestones: Celanese's Journey
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Decline in Revenue: Over the 3 months period, Celanese faced challenges, resulting in a decline of approximately -8.48% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Celanese's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.63% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Celanese's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.71%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Celanese's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.46%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Celanese's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.96, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
How Are Analyst Ratings Determined?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
